Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
Revelation Biosciences will implement a 1-for-7 reverse stock split effective at the open on October 20, 2026, with shares continuing to trade under the REVB symbol. The stated purpose is to lift the per-share price enough to regain compliance with Nasdaq Capital Market's minimum bid price continued-listing requirement. Warrants, options, RSUs and equity plan share counts will be proportionately adjusted; fractional shares will be rounded up.
Key figures
- New cusip
- 76135L887
- Effective date
- 2026-10-20
- Reverse split ratio
- 1-for-7
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.